DSCO Phase II Surfaxin ARDS data

Discovery Laboratories (DSCO) was up $1.40 (21%) to $8.22 on 3.7 million shares on Tuesday after preliminary Phase II data showed that

Read the full 221 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE